Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry

Bente Glintborg; Dorte Vendelbo Jensen; Sara Engel; Lene Terslev; Mogens Pfeiffer Jensen; Oliver Hendricks; Mikkel Østergaard; Simon Horskjær Rasmussen; Thomas Adelsten; Ada Colic; Kamilla Danebod; Malene Kildemand; Anne Gitte Loft; Heidi Lausten Munk; Jens Kristian Pedersen; René Drage Østgård; Christian Møller Sørensen; Niels Steen Krogh; Jette Nørgaard Agerbo; Connie Ziegler; Merete Lund Hetland

doi:10.1136/rmdopen-2021-001649

Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry

Bente Glintborg^*, Dorte Vendelbo Jensen, Sara Engel, Lene Terslev, Mogens Pfeiffer Jensen, Oliver Hendricks, Mikkel Østergaard, Simon Horskjær Rasmussen, Thomas Adelsten, Ada Colic, Kamilla Danebod, Malene Kildemand, Anne Gitte Loft, Heidi Lausten Munk, Jens Kristian Pedersen, René Drage Østgård, Christian Møller Sørensen, Niels Steen Krogh, Jette Nørgaard Agerbo, Connie ZieglerMerete Lund Hetland

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

18 Downloads (Pure)

Original language	English
Article number	e001649
Journal	RMD Open
Volume	7
Issue number	2
Number of pages	3
ISSN	2056-5933
DOIs	https://doi.org/10.1136/rmdopen-2021-001649
Publication status	Published - 3. May 2021

Keywords

arthritis
COVID-19
patient reported outcome measures

Documents & Links

10.1136/rmdopen-2021-001649Licence: CC BY-NC

Open Access VersionFinal published version, 725 KBLicence: CC BY-NC

Cite this

Glintborg, B., Jensen, D. V., Engel, S., Terslev, L., Pfeiffer Jensen, M., Hendricks, O., Østergaard, M., Horskjær Rasmussen, S., Adelsten, T., Colic, A., Danebod, K., Kildemand, M., Loft, A. G., Munk, H. L., Pedersen, J. K., Østgård, R. D., Møller Sørensen, C., Krogh, N. S., Nørgaard Agerbo, J., ... Lund Hetland, M. (2021). Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry. RMD Open, 7(2), [e001649]. https://doi.org/10.1136/rmdopen-2021-001649

@article{29ee0d4d12f34d55b12a1cd58cf41b1f,

title = "Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry",

keywords = "arthritis, COVID-19, patient reported outcome measures",

author = "Bente Glintborg and Jensen, {Dorte Vendelbo} and Sara Engel and Lene Terslev and {Pfeiffer Jensen}, Mogens and Oliver Hendricks and Mikkel {\O}stergaard and {Horskj{\ae}r Rasmussen}, Simon and Thomas Adelsten and Ada Colic and Kamilla Danebod and Malene Kildemand and Loft, {Anne Gitte} and Munk, {Heidi Lausten} and Pedersen, {Jens Kristian} and {\O}stg{\aa}rd, {Ren{\'e} Drage} and {M{\o}ller S{\o}rensen}, Christian and Krogh, {Niels Steen} and {N{\o}rgaard Agerbo}, Jette and Connie Ziegler and {Lund Hetland}, Merete",

note = "Funding Information: Funding This study was partly funded by an unrestricted grant from The Lundbeck Foundation (grant number R349-2020-629). Funding Information: Competing interests BG: Research grants: AbbVie, BMS, Pfizer. OH: Research grants: AbbVie, Novartis, Pfizer. LT: Speakers fee: Speakers fee from AbbVie, Janssen, Roche, Novartis, Pfizer, MSD, BMS and GE. MO: Research grants: Abbvie, BMS, Celgene, Merck, Novartis; consultancy and/or speaker fees: Abbvie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Hospira, Janssen, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, Sandoz, Sanofi and UCB. RDO: Research grants: Abbvie; consultancy and/or speaker fees: Abbvie, BMS, Boehringer-Ingelheim, Eli-Lilly, Janssen, Merck, Novartis, Pfizer, Roche, Sanofi and UCB. AGL: Consultancy and/or speakers fees: AbbVie, Eli-Lilly, Janssen, MSD, Novartis, Pfizer and UCB. MLH: AbbVie, Biogen, BMS, Celtrion, Eli Lilly Denmark A/S, Janssen Biologics B.V, Lundbeck Fonden, MSD, Pfizer, Roche, Samsung Biopis, Sandoz. MLH chairs the steering committee of the Danish Rheumatology Quality Registry (DANBIO), which receives public funding from the hospital owners and funding from pharmaceutical companies. MLH co-chairs the EuroSpA research collaboration, which generates real-world evidence of treatment of psoriatic arthritis and axial spondylorthritis based on secondary data and is partly funded by Novartis.",

year = "2021",

month = may,

day = "3",

doi = "10.1136/rmdopen-2021-001649",

language = "English",

volume = "7",

journal = "RMD Open",

issn = "2056-5933",

publisher = "BMJ Group",

number = "2",

}

Glintborg, B, Jensen, DV, Engel, S, Terslev, L, Pfeiffer Jensen, M, Hendricks, O, Østergaard, M, Horskjær Rasmussen, S, Adelsten, T, Colic, A, Danebod, K, Kildemand, M, Loft, AG, Munk, HL, Pedersen, JK, Østgård, RD, Møller Sørensen, C, Krogh, NS, Nørgaard Agerbo, J, Ziegler, C & Lund Hetland, M 2021, 'Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry', RMD Open, vol. 7, no. 2, e001649. https://doi.org/10.1136/rmdopen-2021-001649

Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry. / Glintborg, Bente; Jensen, Dorte Vendelbo; Engel, Sara et al.

In: RMD Open, Vol. 7, No. 2, e001649, 03.05.2021.

Research output: Contribution to journal › Journal article › Research › peer-review

TY - JOUR

T1 - Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry

AU - Glintborg, Bente

AU - Jensen, Dorte Vendelbo

AU - Engel, Sara

AU - Terslev, Lene

AU - Pfeiffer Jensen, Mogens

AU - Hendricks, Oliver

AU - Østergaard, Mikkel

AU - Horskjær Rasmussen, Simon

AU - Adelsten, Thomas

AU - Colic, Ada

AU - Danebod, Kamilla

AU - Kildemand, Malene

AU - Loft, Anne Gitte

AU - Munk, Heidi Lausten

AU - Pedersen, Jens Kristian

AU - Østgård, René Drage

AU - Møller Sørensen, Christian

AU - Krogh, Niels Steen

AU - Nørgaard Agerbo, Jette

AU - Ziegler, Connie

AU - Lund Hetland, Merete

N1 - Funding Information: Funding This study was partly funded by an unrestricted grant from The Lundbeck Foundation (grant number R349-2020-629). Funding Information: Competing interests BG: Research grants: AbbVie, BMS, Pfizer. OH: Research grants: AbbVie, Novartis, Pfizer. LT: Speakers fee: Speakers fee from AbbVie, Janssen, Roche, Novartis, Pfizer, MSD, BMS and GE. MO: Research grants: Abbvie, BMS, Celgene, Merck, Novartis; consultancy and/or speaker fees: Abbvie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Hospira, Janssen, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, Sandoz, Sanofi and UCB. RDO: Research grants: Abbvie; consultancy and/or speaker fees: Abbvie, BMS, Boehringer-Ingelheim, Eli-Lilly, Janssen, Merck, Novartis, Pfizer, Roche, Sanofi and UCB. AGL: Consultancy and/or speakers fees: AbbVie, Eli-Lilly, Janssen, MSD, Novartis, Pfizer and UCB. MLH: AbbVie, Biogen, BMS, Celtrion, Eli Lilly Denmark A/S, Janssen Biologics B.V, Lundbeck Fonden, MSD, Pfizer, Roche, Samsung Biopis, Sandoz. MLH chairs the steering committee of the Danish Rheumatology Quality Registry (DANBIO), which receives public funding from the hospital owners and funding from pharmaceutical companies. MLH co-chairs the EuroSpA research collaboration, which generates real-world evidence of treatment of psoriatic arthritis and axial spondylorthritis based on secondary data and is partly funded by Novartis.

PY - 2021/5/3

Y1 - 2021/5/3

KW - arthritis

KW - COVID-19

KW - patient reported outcome measures

U2 - 10.1136/rmdopen-2021-001649

DO - 10.1136/rmdopen-2021-001649

M3 - Journal article

C2 - 33941664

AN - SCOPUS:85105248472

VL - 7

JO - RMD Open

JF - RMD Open

SN - 2056-5933

IS - 2

M1 - e001649

ER -